There was a significant stepwise increase of Beclin1 positivity between the three studied groups starting from BPH up to the highest percentage of positive cases appeared in prostatic carcinoma passing through a group of BPH adjacent to tumor. This evidence concerns the gene BECN1 and prostate carcinoma.